Analysis of the Bim/Dlc protein complex regulating the survival of hematopoietic cells under the control of cytokines.
Analysis of the Bim/Dlc protein complex regulating the survival of hematopoietic cells under the control of cytokines.
批准号:
14370303
负责人:
INABA Toshiya
金额:
$8.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Expression control systems were analyzed by DNase hypersensitivity assay, reporter analysis, gelshift assay, nuclear run off assay, and experiments monitoring the half life of mRNA. By reporter assay, we isolated cis-elements, which upregulate(several hundreds base pairs upstream of the transcriptional initiation site) or downregulate (in the first intron) the transcriptional efficiencies. Unexpectedly, the silencer sequence in the first intron is cytokine independent. Moreover, nuclear run off assay suggested that the expression of Bim is not controlled by transcriptional mechanisms, but by the regulation of the half-life of its message. Therefore, Bim mRNA is likely regulated by modification of mRNA degradation. In vitro assay, the half-life of Bim mRNA was elongated by cytokines. We found that this is mediated by heat shock cognate protein(Hsc70), which binds and stabilizes the mRNA. The binding potential of Hsc70 to mRNA is turned out to be regulated by cochaperons such as Hsp40, Hip, and Bag proteins.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Matsunaga T.: "Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein"Blood. (in press).
Matsunaga T.:“细胞因子引发的信号通路和 E2A-HLF 癌蛋白对膜联蛋白 II 的调节”血液。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeshita A.et al.: "Del(6p23) and der(11p15) including NUP98 translocation in a case of secondary myeloproliferative disorder which eventually underwent clonal evolution and transformed to acute myeloid leukemia"Cancer Genet. Cytogenet.. (in press ).
Takeshita A.等人:“继发性骨髓增生性疾病病例中的 Del(6p23) 和 der(11p15) 包括 NUP98 易位,最终经历克隆进化并转化为急性髓性白血病”Cancer Genet。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kuribara R.et al.: "Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoictic progenitors"Mol. Cell. Biol.. (in press ).
Kuribara R.等人:“Bim 在正常和表达 Bcr-Abl 的造血祖细胞凋亡中的作用”Mol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeshita A.: "Del(6p23) and der(11p15) including NUP98 translocation in a case of secondary myeloproliferative disorder which eventually underwent clonal evolution and transformed to acute myeloid leukemia."Cancer Genet.Cytogenet.. (in press).
Takeshita A.:“Del(6p23) 和 der(11p15),包括继发性骨髓增殖性疾病病例中的 NUP98 易位,最终经历克隆进化并转化为急性髓系白血病。”Cancer Genet.Cytogenet..(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsunaga T.et al.: "Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein"Blood. 103. 3185-3191 (2004)
Matsunaga T.等人:“细胞因子引发的信号通路和 E2A-HLF 癌蛋白对膜联蛋白 II 的调节”血液。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Roles of impairment of centrosome maturation in leukemogenesis
-
批准号:23390253
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.31万
-
财政年份:2011
-
负责人:INABA Toshiya
-
依托单位:
Isolation and characterization of genes involved in the abnormalities of mitosis and nuclear morphology found in myelodysplastic syndromes.
-
批准号:22659181
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.01万
-
财政年份:2010
-
负责人:INABA Toshiya
-
依托单位:
Functional analysis of candidate responsible genes for 7q deletion in MDS/AML
-
批准号:20390271
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2008
-
负责人:INABA Toshiya
-
依托单位:
Isolation and characterization of candidate myeloid tumor-suppressor genes on the long arm of chromosome7.
-
批准号:18390284
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.23万
-
财政年份:2006
-
负责人:INABA Toshiya
-
依托单位:
Analysis of expression control of the Bim gene.
-
批准号:16390279
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:2004
-
负责人:INABA Toshiya
-
依托单位:
Functional analysis of the Bim/DLC complex in apoptosis regulation of hematopoietic progenitors
-
批准号:12470205
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$2.69万
-
财政年份:2000
-
负责人:INABA Toshiya
-
依托单位:
TEL-AML1融合転写調節因子の発癌機序の分析
-
批准号:10670965
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:INABA Toshiya
-
依托单位:
国内基金
海外基金
登录
查看更多内容
UBE2D2负调控p27抑制细胞衰老促进胶质瘤进展的机制研究
-
批准号:2026JJ80431
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙学志
-
依托单位:
基于p27(KIP1)的磷酸化和亚细胞定位探讨周围神经修复机制及中药干预研究
-
批准号:2025JJ80967
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李洪辉
-
依托单位:
p27介导细胞铁死亡改善卵巢癌铂耐药的作用及机制研究
-
批准号:JCZRYB202500413
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
衰老性 Lamin A-Sirt6-P27 在衰老性脂肪组织
再分布中的作用研究
-
批准号:Q24H070004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨甜
-
依托单位:
E3泛素连接酶RNF6促进p27的泛素化降解影响胶质母细胞瘤的增殖和化疗敏感性
-
批准号:82103156
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:侯建兵
-
依托单位:
Ambra1通过Akt磷酸化FoxO1抑制p27转录促进乳腺癌细胞增殖和肿瘤发生的机制研究
-
批准号:82160499
-
项目类别:地区科学基金项目
-
资助金额:34.1万元
-
批准年份:2021
-
负责人:孙蔚亮
-
依托单位:
CDK2/p27/SKP2网络对视网膜母细胞瘤Y79细胞株c-MYC蛋白影响的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:
-
依托单位:
MLF1IP通过BRCA1/AKT/p27信号轴促进结直肠癌细胞增殖的机制研究
-
批准号:82002919
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:徐玉婷
-
依托单位:
SIRT2/TGF/smad/p27通路表观调控特发性肺纤维化的机制
-
批准号:2020JJ5802
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:段娟
-
依托单位:
p27上调PHLPP1改善卵巢癌铂耐药的机制研究
-
批准号:82002771
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:彭明刚
-
依托单位: